Walgreens Boots Alliance (NASDAQ:WBA) Issues Quarterly Earnings Results

Walgreens Boots Alliance (NASDAQ:WBA) posted its quarterly earnings data on Tuesday. The pharmacy operator reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.03, Briefing.com reports. The firm had revenue of $37.50 billion during the quarter, compared to analysts’ expectations of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.67 EPS. Walgreens Boots Alliance updated its FY 2025 guidance to 1.400-1.800 EPS and its FY25 guidance to $1.40-$1.80 EPS.

Walgreens Boots Alliance Stock Down 4.9 %

WBA traded down $0.54 during trading on Thursday, reaching $10.53. The company had a trading volume of 8,701,844 shares, compared to its average volume of 17,003,760. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31. Walgreens Boots Alliance has a 12 month low of $8.22 and a 12 month high of $27.05. The business’s fifty day moving average price is $9.41 and its 200 day moving average price is $13.22. The company has a market cap of $9.09 billion, a P/E ratio of -1.64, a PEG ratio of 1.06 and a beta of 0.70.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on WBA shares. Bank of America lowered their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. Barclays lifted their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday. Evercore ISI lifted their price target on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research report on Wednesday. JPMorgan Chase & Co. lowered their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. Finally, Truist Financial lowered their price target on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research report on Monday, October 7th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Walgreens Boots Alliance has an average rating of “Hold” and an average price target of $13.54.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.